全文获取类型
收费全文 | 154761篇 |
免费 | 45853篇 |
国内免费 | 1422篇 |
专业分类
耳鼻咽喉 | 2035篇 |
儿科学 | 5896篇 |
妇产科学 | 901篇 |
基础医学 | 30618篇 |
口腔科学 | 7146篇 |
临床医学 | 16210篇 |
内科学 | 31720篇 |
皮肤病学 | 5127篇 |
神经病学 | 22509篇 |
特种医学 | 6503篇 |
外国民族医学 | 4篇 |
外科学 | 18677篇 |
综合类 | 4456篇 |
现状与发展 | 2篇 |
一般理论 | 8篇 |
预防医学 | 9918篇 |
眼科学 | 1874篇 |
药学 | 18822篇 |
6篇 | |
中国医学 | 3297篇 |
肿瘤学 | 16307篇 |
出版年
2023年 | 919篇 |
2022年 | 1770篇 |
2021年 | 3442篇 |
2020年 | 7316篇 |
2019年 | 13008篇 |
2018年 | 12400篇 |
2017年 | 13426篇 |
2016年 | 12251篇 |
2015年 | 12386篇 |
2014年 | 12853篇 |
2013年 | 13589篇 |
2012年 | 12177篇 |
2011年 | 12567篇 |
2010年 | 10907篇 |
2009年 | 7351篇 |
2008年 | 8006篇 |
2007年 | 6255篇 |
2006年 | 5897篇 |
2005年 | 5424篇 |
2004年 | 5242篇 |
2003年 | 4728篇 |
2002年 | 4215篇 |
2001年 | 3211篇 |
2000年 | 2151篇 |
1999年 | 909篇 |
1998年 | 718篇 |
1997年 | 649篇 |
1996年 | 570篇 |
1995年 | 524篇 |
1994年 | 453篇 |
1993年 | 437篇 |
1992年 | 428篇 |
1991年 | 385篇 |
1990年 | 322篇 |
1989年 | 295篇 |
1988年 | 240篇 |
1987年 | 244篇 |
1986年 | 231篇 |
1985年 | 490篇 |
1984年 | 597篇 |
1983年 | 392篇 |
1982年 | 447篇 |
1981年 | 403篇 |
1980年 | 346篇 |
1979年 | 321篇 |
1978年 | 275篇 |
1977年 | 185篇 |
1976年 | 167篇 |
1975年 | 132篇 |
1974年 | 104篇 |
排序方式: 共有10000条查询结果,搜索用时 640 毫秒
41.
42.
43.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies
下载免费PDF全文
![点击此处可从《Journal of viral hepatitis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
44.
45.
Peng‐fei Lei Shi‐long Su Ling‐yu Kong Cheng‐gong Wang Da Zhong Yi‐he Hu 《Orthopaedic Surgery》2019,11(5):914-920
Three‐dimensional (3D) printing technology, virtual reality, and augmented reality technology have been used to help surgeons to complete complex total hip arthroplasty, while their respective shortcomings limit their further application. With the development of technology, mixed reality (MR) technology has been applied to improve the success rate of complicated hip arthroplasty because of its unique advantages. We presented a case of a 59‐year‐old man with an intertrochanteric fracture in the left femur, who had received a prior left hip fusion. After admission to our hospital, a left total hip arthroplasty was performed on the patient using a combination of MR technology and 3D printing technology. Before surgery, 3D reconstruction of a certain bony landmark exposed in the surgical area was first performed. Then a veneer part was designed according to the bony landmark and connected to a reference registration landmark outside the body through a connecting rod. After that, the series of parts were made into a holistic reference registration instrument using 3D printing technology, and the patient's data for bone and surrounding tissue, along with digital 3D information of the reference registration instrument, were imported into the head‐mounted display (HMD). During the operation, the disinfected reference registration instrument was installed on the selected bony landmark, and then the automatic real‐time registration was realized by HMD through recognizing the registration landmark on the reference registration instrument, whereby the patient's virtual bone and other anatomical structures were quickly and accurately superimposed on the real body of the patient. To the best of our knowledge, this is the first report to use MR combined with 3D printing technology in total hip arthroplasty. 相似文献
46.
47.
48.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features
下载免费PDF全文
![点击此处可从《Histopathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
49.
目的观察比较CO2点阵激光早期控制唇裂术后二期整复术术区瘢痕的临床疗效。方法治疗组为43例接受唇裂术后鼻唇畸形二期整复术的患者,早期采用CO2点阵激光治疗,对照组为70例曾接受一期唇裂手术的患者,对两组6个月后的瘢痕恢复情况进行比较;分析术后距离激光开始治疗时间的长短,性别两因素对激光治疗瘢痕疗效的差异。结果1)治疗组的疗效优于对照组(P<0.000 1),治疗组中显效和有效所组成的总有效率达90.7%;2)男女疗效差异无统计学意义(P=0.487),手术后1年内的患者,手术后距离开始瘢痕治疗的时间<3个月与≥3个月之间,疗效无明显统计学差异(P=0.055)。结论CO2点阵激光在唇裂二期整复术术后瘢痕的治疗中具有较为确切的疗效。且与患者的性别无明显相关性。手术后1年内的患者,术后距离开始瘢痕治疗的时间<3个月和≥3个月疗效无差异,因此在唇裂二期手术后的1年内早期对瘢痕进行干预可获得良好的效果。 相似文献
50.